Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping Therapeutic Regulatory T Cell Fate with MRI: Current Strategies and Translational Outlook.

Nanomaterials (Basel, Switzerland)·2026
Same author

Macrophage-derived fibronectin suppresses antitumor immunity via tissue stiffening and immunosuppressive cell induction in cancer mouse models.

Nature communications·2026
Same author

Targeting cysteinyl leukotriene receptor 1 reprograms tumor-promoting myelopoiesis and overcomes immune checkpoint therapy resistance.

Nature cancer·2026
Same author

Citraconate preserves T cell stemness and antitumor immunity.

Science immunology·2026
Same author

Efficacy and immunomodulatory effect of Claudin18.2-specific IL-7/XCL1 armored CAR-T cells in digestive tract cancer: preclinical and clinical analysis.

Signal transduction and targeted therapy·2026
Same author

Neurotransmitters: Key regulators of the tumor immune microenvironment.

Seminars in immunology·2026

Related Experiment Video

Updated: May 29, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

400

Modulating lipid metabolism improves tumor immunotherapy.

Yu Ping1, Qiuqing Fan1, Yi Zhang2,3,4,5,6

  • 1Biotherapy Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.

Journal for Immunotherapy of Cancer
|February 4, 2025
PubMed
Summary

Abnormal lipid metabolism in cancer hinders immunotherapy. A new scoring system and targeting fatty acid oxidation show promise for improving cancer immunotherapy outcomes.

Keywords:
Immunotherapy

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

624
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.4K

Related Experiment Videos

Last Updated: May 29, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

400
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

624
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
07:44

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports

Published on: November 28, 2019

7.4K

Area of Science:

  • Oncology
  • Immunology
  • Cancer Metabolism

Background:

  • Cancer immunotherapy effectiveness is limited by various factors.
  • Abnormal lipid metabolism is common in cancers, promoting tumor growth and spread.
  • Lipid metabolism influences the tumor microenvironment and immune cell function.

Purpose of the Study:

  • To investigate the role of lipid metabolism in cancer immunotherapy.
  • To develop a lipid metabolism scoring system for predicting immunotherapy outcomes.
  • To explore the impact of targeting lipid metabolism on immune cell infiltration and immunotherapy efficacy.

Main Methods:

  • Construction of a lipid metabolism scoring system.
  • Investigating the effect of MK1775 on fatty acid oxidation in tumor-associated macrophages.
  • Assessing T-cell infiltration and immunotherapy efficacy.

Main Results:

  • A lipid metabolism scoring system was developed.
  • MK1775 inhibited fatty acid oxidation in tumor-associated macrophages.
  • Reduced fatty acid oxidation enhanced T-cell infiltration and immunotherapy efficacy.

Conclusions:

  • Lipid metabolism plays a critical role in cancer immunotherapy.
  • A lipid metabolism scoring system can aid in predicting treatment outcomes.
  • Targeting lipid metabolism offers a novel strategy for combination cancer therapy to improve immunotherapy.